Product NDC: | 76325-100 |
Proprietary Name: | Ravicti |
Non Proprietary Name: | glycerol phenylbutyrate |
Active Ingredient(s): | 1.1 g/mL & nbsp; glycerol phenylbutyrate |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 76325-100 |
Labeler Name: | Hyperion Therapeutics, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA203284 |
Marketing Category: | NDA |
Start Marketing Date: | 20130228 |
Package NDC: | 76325-100-25 |
Package Description: | 1 BOTTLE in 1 CARTON (76325-100-25) > 25 mL in 1 BOTTLE |
NDC Code | 76325-100-25 |
Proprietary Name | Ravicti |
Package Description | 1 BOTTLE in 1 CARTON (76325-100-25) > 25 mL in 1 BOTTLE |
Product NDC | 76325-100 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | glycerol phenylbutyrate |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20130228 |
Marketing Category Name | NDA |
Labeler Name | Hyperion Therapeutics, Inc. |
Substance Name | GLYCEROL PHENYLBUTYRATE |
Strength Number | 1.1 |
Strength Unit | g/mL |
Pharmaceutical Classes |